Gilead Withdraws Request for Special Orphan Status on Experimental Virus Treatment

Critics said the company was profiteering from the coronavirus pandemic by seeking tax and monopoly benefits under a program intended to encourage drug development for rare diseases.
By BY KATIE THOMAS from NYT Health https://ift.tt/2xli8yT
via IFTTT
Drugs (Pharmaceuticals), Remdesivir (Drug), your-feed-healthcare, Coronavirus (2019-nCoV)
Source New York Times
Làm đẹp Blog 247